Literature DB >> 6994875

The endocrinology of breast cancer.

S G Korenman.   

Abstract

Endocrine studies relating to breast cancer are reviewed and the conclusion is reached that studies of hormone levels and hormone excretion to date are inconsistent and inadequate to explain the epidemiologic characteristics of the disease. A new paradigm termed the "estrogen window hypothesis" is introduced. Breast cancer risk is related to the duration of unopposed estrogen exposure during puberty and the early postmenarchial period and during the perimenopausal period. These two estrogen windows provide periods of maximum inducibility by environmental carcinogens. The hypothesis is supported by studies of the survivors of the atomic bomb blasts in Hiroshima and Nagasaki and of women having repeated fluoroscopy for management of tuberculosis. The hypothesis generates many testable conclusions. If verified, the hypothesis could lead to significant public health initiatives.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6994875     DOI: 10.1002/1097-0142(19800815)46:4+<874::aid-cncr2820461305>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Breast cancer, pregnancy, and the pill.

Authors:  J O Drife
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-19

2.  Factors associated with age at diagnosis of breast cancer.

Authors:  Y A Duralde; R H Byers; C D Stevens; R W Powell
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-06

3.  Luteal phase defect and breast cancer genesis.

Authors:  P Mauvais-Jarvis; R Sitruk-Ware; F Kuttenn
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

Review 4.  Sex steroids and cancer in older women.

Authors:  T R Varma
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

Review 5.  Physiologic effects of steroid hormones and postmenopausal hormone replacement on the female breast and breast cancer risk.

Authors:  I A Mustafa; K I Bland
Journal:  Ann Surg       Date:  1998-11       Impact factor: 12.969

6.  Metabolism of debrisoquine and susceptibility to breast cancer.

Authors:  J Huober; B Bertram; E Petru; M Kaufmann; D Schmähl
Journal:  Breast Cancer Res Treat       Date:  1991-03       Impact factor: 4.872

Review 7.  Antiestrogen action of progesterone in breast tissue.

Authors:  P Mauvais-Jarvis; F Kuttenn; A Gompel
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

8.  Glycoprotein components in the serum of patients with cancer breast.

Authors:  M Varkey; R S Devi; S B Rao
Journal:  Indian J Clin Biochem       Date:  1997-12

9.  Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors.

Authors:  R Cooke; M E Jones; D Cunningham; S J Falk; D Gilson; B W Hancock; S J Harris; A Horwich; P J Hoskin; T Illidge; D C Linch; T A Lister; H H Lucraft; J A Radford; A M Stevens; I Syndikus; M V Williams; A J Swerdlow
Journal:  Br J Cancer       Date:  2013-05-07       Impact factor: 7.640

10.  The effect of age and menstrual cycle upon proliferative activity of the normal human breast.

Authors:  C S Potten; R J Watson; G T Williams; S Tickle; S A Roberts; M Harris; A Howell
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.